Sageworth Trust CO Bristol Myers Squibb CO Transaction History

Sageworth Trust CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$65.71 - $74.53 $1,051 - $1,192	-16 Reduced 1.22%	1,300 $90,000
Q4 2022 Jan 25, 2023	BUY	$68.48 - $81.09 $1,095 - $1,297	16 Added 1.23%	1,316 $95,000
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $79,924 - $95,836	1,300 New	1,300 $95,000
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $10,354 - $12,129	-175 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$57.43 - $63.64 $1,320 - $1,463	-23 Reduced 11.62%	175 $11,000
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $1,260 - $1,474	23 Added 13.14%	198 $12,000
Q4 2019 Jan 28, 2020	BUY	$49.21 - $64.19 $8,611 - $11,233	175 New	175 $11,000
Q2 2019 Jul 19, 2019	SELL	$44.62 - $49.34 $8,924 - $9,868	-200 Closed	0 $0
Q1 2019 Apr 08, 2019	SELL	$45.12 - $53.8 $18,048 - $21,520	-400 Reduced 66.67%	200 $10,000
Q3 2018 Oct 30, 2018	BUY	$55.19 - $62.25 $22,076 - $24,900	400 Added 200.0%	600 $37,000
Q2 2018 Jul 19, 2018	BUY	$50.53 - $62.98 $10,106 - $12,596	200 New	200 $11,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sageworth Trust CO, based on Form 13F filings with the SEC.

Stay updated on Sageworth Trust CO with notifications on news.